Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model

Food and Chemical Toxicology

Volumn 48, Issue 10, 2010, Pages 2791-2796

  Król, Ewelina ^a   Krejpcio, Zbigniew ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Chromium(III) propionate complex; Insulin resistance; Rat

Indexed keywords

ANTIDIABETIC AGENT; CHROMIUM; CHROMIUM PROPIONATE; GLUCOSE; INSULIN; IRON; LIPID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; NONHUMAN; NUTRITIONAL PARAMETERS; RAT; THERAPY EFFECT; TREATMENT DURATION;

ANIMALS; BLOOD CELL COUNT; BLOOD CELLS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIET; FRUCTOSE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METALS; PROPIONIC ACIDS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77956339657     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.07.008     Document Type: Article

References (60)

1. American Diabetes Association A position statement of the American Diabetes Association. Nutrition recommendations and interventions for diabetes. Diabetes Care 2008, 31:61-78.
2. Banerji M.A., Faridi N., Atluri R., Chaiken R.L., Lebovitz H.E. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. Journal of Clinical Endocrinology and Metabolism 1999, 84:137-144.
3. Bartlett H.E., Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic and Physiological Optic 2008, 28:503-523.
4. Bailey M., Boohaker J., Sawyer R., Behling J., Rasco J., Jernigan J., Hood R., Vincent J.B. Exposure of pregnant mice to chromium picolinate results in skeletal defects in their offspring. Birth Defects Research 2006, 77:244-249.
5. Cefalu W.T., Rood J., Pinsonat P., Qin J., Sereda O., Levitan L., Anderson R.A., Zhang X.H., Martin J.M., Martin C.K., Wang Z.Q., Newcomer B. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism 2010, 59:755-762.
6. CELL-DYN 1700 System, 1995. Operations Manual. Abbott Laboratories, USA.
7. Chen W.Y., Chen C.J., Liu C.H., Mao F.C. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obesity Metabolism 2009, 11:293-303.
8. Clodfelder B.J., Chang C., Vincent J.B. Absorption of the biomimetic chromium cation triaqua-μ-oxo-hexapropionatotrichromium(III) in rats. Biological Trace Element Research 2004, 98:159-169.
9. Clodfelder B.J., Emamaullee J., Hepburn D.D., Chakov N.E., Nettles H.S., Vincent J.B. The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. Journal of Biological Inorganic Chemistry 2001, 6:608-617.
10. + increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. Journal of Biological Inorganic Chemistry 2005, 10:119-130.
11. Clodfelder B.J., Upchurch R.G., Vincent J.B. A comparison of the insulin-sensitive transport of chromium in healthy and model diabetic rats. Journal of Inorganic Biochemistry 2004, 98:522-533.
12. Clodfelder B.J., Vincent J.B. The time-dependent transport of chromium in adult rats from the bloodstream to the urine. Journal of Biological Inorganic Chemistry 2005, 10:383-393.
13. Davies S., Howard J.M., Hinnisett A., Howard M. Age-related decreases in chromium levels in 51, 665 hair, sweat, and serum samples from 40, 872 patients: Implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 1997, 46:469-473.
14. Dogukan A., Sahin N., Tuzcu M., Juturu V., Orhan C., Onderci M., Komorowski J., Sahin K. The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biological Trace Element Research 2009, 131:124-132.
15. 3 supplementation alters glucose disposal, insulin signaling, and glucose transporter-4 membrane translocation in insulin-resistant mice. Journal of Nutrition 2008, 138:1846-1851.
16. Earnshaw A., Figgis B.N., Lewis J. Chemistry of polynuclear compounds. Part VI. Magnetic properties of trimeric chromium and iron carboxylates. Journal of Chemical Society A 1966, 1656-1663.
17. Gunton J.E., Cheung N.W., Hitchman R., Hams G., O'Sullivan C., Foster-Powell K., O'Sullivan C., McElduff A. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile. Diabetes Care 2005, 28:712-714.
18. Harton A., Terrell K., Huffman J.C., MacDonald C., Beatty A., Li S., O'Connor C.J., Vincent J.B. Synthesis and characterization of novel oxo-bridged dinuclear and hydroxo-bridged trinuclear chromium(III) assemblies. Inorganic Chemistry 1997, 36:4875-4882.
19. Hininger I., Benaraba R., Osman M., Faure H., Roussel A.-M., Anderson R.A. Safety of trivalent chromium complexes: no evidence for DNA damage in human HaCaT keratinocytes. Free Radical Biology and Medicine 2007, 15:1759-1765.
20. Inceli M.S., Bolkent S., Doger M.M., Yanardag R. The effects of combined treatment with niacin and chromium on the renal tissues of hyperlipidemic rats. Molecular and Cellular Biochemistry 2007, 294:37-44.
21. Iqbal N., Cardillo S., Volger S., Bloedon L.T., Anderson R.A., Boston R., Szapary P.O. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults. Metabolic Syndrome and Related Disorders 2009, 7:143-150.
22. Jeejeebhoy K.N., Chu R.C., Marliss E.B., Greenberg G.R., Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. American Journal of Clinical Nutrition 1977, 30:531-538.
23. Kahn S., Hull R., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
24. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.J. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000, 85:2402-2410.
25. Kleefstra N., Houweling S., Jansman F.G.A., Groenier K.H., Gans R.O.B., Mayboom-de Jong B., Bakker S.J.L., Bilo H.J.G. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population. Diabetes Care 2006, 29:321-325.
26. Kuryl T., Krejpcio Z., Wójciak R.W., Lipko M., Debski B., Staniek H. Chromium(III) propionate and dietary fructans supplementation stimulate erythrocyte glucose uptake and beta-oxidation in lymphocytes of rats. Biological Trace Element Research 2006, 114:237-248.
27. Mann J.I., De Leeuw I., Hermansen K., Karamanos B., Karlström B., Katsilambros N., Riccardi G., Rivellese A.A., Rizkalla S., Slama G., Toeller M., Uusitupa M., Vessby B. Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutrition Metabolism and Cardiovascular Diseases 2004, 14:373-394.
28. Martin J., Zhang X.H., Zhong Q., Wang X.H., Wachtel D., Volaufova J., Matthews D.E., Cefalu W.T. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006, 29:1826-1832.
29. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
30. Miki Y. A homogenous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method. Clinical Laboratory 1999, 45:398-401.
31. Mita Y., Ishihara K., Fukuchi Y., Fukuya Y., Yasumoto K. Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biological Trace Element Research 2005, 105:229-248.
32. Mita Y., Ishihara K., Ishiguru M., Takeda M., Hattori R., Murakami K., Yamada A., Yasumoto K. Elevated urinary Cr loss induces a reduction in renal Cr concentration and the negative Cr balance in streptozotocin-induced diabetic mice. Journal of Nutritional Science and Vitaminology 2008, 54:303-308.
33. Morris B.W., MacNeil S., Hardisty C.A., Heller S., Burgin C., Gray T.A. Chromium homeostasis in patients with type II (NIDDM) diabetes. Journal of Trace Elements in Medicine and Biology 1999, 13:57-61.
34. Newmann D.J., Price C.P. Renal function and nitrogen metabolites. Tietz Book of Clinical Chemistry 1999, 1239-1242. WB Saunders Company, Philadelphia. C.A. Burtis, E.R. Ashwood (Eds.).
35. Pei D., Hsieh C.H., Hung Y.J., Li J.C., Lee C.H., Kuo S.W. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 2006, 55:923-927.
36. Racek J., Trefil L., Rajdl D., Mudrova V., Hunter D., Senft V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biological Trace Element Research 2006, 109:215-230.
37. Rajasekar P., Anuradha C.V. Fructose induced gluconeogenesis: effect of l-carnitine. Life Sciences 2007, 80:1176-1183.
38. Rajpathak S., Rimm E.B., Li T., Morris J.S., Stampfer M.J., Willet W.C., Hu F.B. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 2004, 27:2211-2216.
39. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. Journal of Nutrition 1993, 123:1939-1951.
40. Riesen W.F. Lipid metabolism. Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results 1998, 167-169. TH-Books Verlagssesellschaft, Frankfurt Main. L. Thomas (Ed.).
41. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry 2002, 48:436-472.
42. Sahin K., Gülar T., Sahin N., Ertas O.N. The effect of chromium added into basal diet on serum total protein, urea, triglyceride, cholesterol and serum and tissue chromium, zinc, copper levels in rabbits. Turkish Journal of Veterinary and Animal Sciences 1999, 23:113-119.
43. Sahin K., Onderci M., Tuzcu M., Ustundag B., Cikim G., Ozercan I.H., Sriramoju V., Juturu V., Komorowski J.R. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism Clinical and Experimental 2007, 56:1233-1240.
44. Schumann G., Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clinica Chimica Acta 2003, 327:69-79.
45. Seaborn C.D., Stocker B.J. Effects of starch, sucrose, fructose and glucose on chromium absorption and tissue concentrations in obese and lean mice. Journal of Nutrition 1989, 119:1444-1451.
46. Shephard M.D., Whiting M.J. Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen. Clinical Chemistry 1990, 36:325-329.
47. Shinde U.A., Goyal R.K. Effects of chromium picolinate on histopatological alternations in STZ and neonatal STZ diabetic rats. Journal of Cellular and Molecular Medicine 2003, 7:322-329.
48. Speetjens J.K., Collins R.A., Vincent J.B., Woski S.A. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chemical Research in Toxicology 1999, 12:483-487.
49. + do not cleave DNA under physiologically relevant conditions. Polyhedron 1999, 18:2617-2624.
50. Staniek H., Krejpcio Z. The effects of tricentric chromium(III) propionate complex supplementation on pregnancy outcome and maternal and foetal mineral status in rat. Food and Chemical Toxicology 2009, 47:2673-2678.
51. Staniek H., Kostrzewska-Poczekaj M., Arndt M., Szyfter K., Krejpcio Z. Genotoxicity assessment of chromium(III) propionate complex in the rat model using the comet assay. Food and Chemical Toxicology 2010, 48:89-92.
52. Staniek H., Krejpcio Z., Iwanik K. Evaluation of the acute oral toxicity class of tricentric chromium(III) propionate complex in rat. Food and Chemical Toxicology 2010, 48:859-864.
53. + decreases plasma insulin, cholesterol, and triglicerides in healthy and type II diabetic rats but not type I diabetic rats. Journal of Biological Inorganic Chemistry 2002, 7:852-862.
54. Scibor A., Zaporowska H. Effects of vanadium(V) and/or chromium(III) on l-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney. Journal of Toxicology and Environmental Health. Part A 2007, 70:696-704.
55. Thomas L. Total protein. Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboartory Results 1998, 644-647. TH-Books Verlagsgesellschaft, FrankfuntMain. L. Thomas (Ed.).
56. Xu Q., Guo J. Activity and toxicity of Cr(III)-enriched Grifola frondosa in insulin-resistant mice. Biological Trace Element Research 2009, 131:271-277.
57. Yadav H., Jain S., Yadav M., Sinha P.R., Prasad G.B., Marotta F. Epigenomic derangement of hepatic glucose metabolism by feeding of high-fructose diet and its prevention by Rosiglitazone in rats. Digestive and Liver Disease 2009, 41:500-508.
58. Vincent J.B. Elucidating a biological role for chromium at a molecular level. Accounts of Chemical Research 2000, 37:503-510.
59. Wang Z.Q., Qin J., Martin J., Zhang X.H., Sereda O., Anderson R.A., Pinsonatm P., Cefalu W.T. Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. Metabolism Clinical and Experimental 2007, 56:1652-1655.
60. Wieloch A., Wieczorek D., Staniek H., Szymusiak H., Krejpcio Z., Zieliński R. Tricentric complexes of chromium(III) with glycine and serie ligands. Current Trends in Commodity Science II 2007, 1080:1086.